Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts.
Current regimens for induction therapy of pediatric acute lymphoblastic leukemia (ALL), or for re-induction post relapse, use a combination of vincristine (VCR), a glucocorticoid, and L-asparaginase (ASP) with or without an anthracycline. With cure rates now approximately 80%, robust pre-clinical mo...
Enregistré dans:
Auteurs principaux: | Barbara Szymanska, Urszula Wilczynska-Kalak, Min H Kang, Natalia L M Liem, Hernan Carol, Ingrid Boehm, Daniel Groepper, C Patrick Reynolds, Clinton F Stewart, Richard B Lock |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/88670b55056c4fe1b0a9b4f77ad7b243 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
par: Shen Yaqing, et autres
Publié: (2021) -
ASSOCIATION OF HYPERDIPLOIDY WITH REMISSION STATUS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AFTER INDUCTION THERAPY
par: Saqib Hussain Korejo, et autres
Publié: (2019) -
Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia
par: Xiaoming Liu, et autres
Publié: (2021) -
Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia
par: Shumaila Sayyab, et autres
Publié: (2021) -
Oral microbiota distinguishes acute lymphoblastic leukemia pediatric hosts from healthy populations.
par: Yan Wang, et autres
Publié: (2014)